1 / 34

Antianginal Dr ugs

Antianginal Dr ugs. Prof.AzzaEL-Medany. Angina pectoris. Sudden,severe,pressing chest pain starting substernal &radiate to left arm. Due to imbalance between myocardium oxygen requirement and oxygen supply. Risk Factors. Age Sex Obesity Smoking Diabetes. Classification of angina

pattersonb
Download Presentation

Antianginal Dr ugs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Antianginal Drugs Prof.AzzaEL-Medany

  2. Angina pectoris • Sudden,severe,pressing chest pain starting substernal &radiate to left arm. • Due to imbalance between myocardium oxygen requirement and oxygen supply.

  3. RiskFactors • Age • Sex • Obesity • Smoking • Diabetes

  4. Classification of angina • Exertional angina, Stable, Atherosclerotic or Classic, Due to obstruction of coronaries by atheroma. • Prinzmetal(Variant or vasospastic ) Due to Spasm of coronaries.

  5. Continue 3- Unstable angina Due to spasm and partial obstruction of coronaries 4- Silent angina

  6. Nitrates & Nitrites • Preparations : 1- Short acting: Start within few minutes and total duration of action 15-30 minutes. A) Nitroglycerine (Glyceryltrinitrate) Used as sublingual tablets. B) Isosorbidedinitrate As sublingual spray. C) Amyl nitrite • Inhalation

  7. Continue 2- long acting Nitroglycerine, Isosorbidedinitrate,Isosorbidemononitrate. • Delayed onset of action and continue for hours . • Given : Orally,Ointment,Transdermalpatch, Intravenous.

  8. Pharmacokinetics • Absorption Well absorbed according to the route of administration

  9. Continue • Metabolism Through first pass hepatic metabolism. Shortacting not given orally to avoid firstpass metabolism. Nitroglycerine & Isosorbidedinitrate have active metabolites.

  10. Continue • Excretion Through the kidney.

  11. Mechanism of action Glutathione S-transferase • Nitroglycerine———————— Nitric oxide ( NO). • NO activates guanylyl cyclase and increasec GMPc GMP dephosphorylatemyosin light chain • Causing smooth muscle relaxation.

  12. Pharmacological actions • Nitrates relax all types of smooth muscles vascular or non vascular . • Potent venodilator. • Have no effect on cardiac or skeletal muscles. • NO released stimulate guanylyl cyclase in platelets causing increase cGMP that decrease platelet aggregation.

  13. Clinical uses • Effective in all types of angina: Short acting for acute attacksLong acting for prophylactic. • Severe heart failure.

  14. Angina of effort • Decrease preload ( increase venous capacitance ) • Decrease afterload decrease myocardial oxygen requirement. • Redistribution of coronary blood flow. • Prevent platelet aggregation

  15. Variant angina • Relax smooth muscle of epicardial coronaryartery and relief coronary spasm.

  16. Unstable angina • Decrease myocardial oxygen requirement. • Relief coronary spasm. • Decrease platelet aggregation.

  17. Adverse effects • Orthostatic hypotension & syncope • Palpitation & Tachycardia • Salt & water retention • Throbbing headache • Facial flushing • Tolerance • Carcinogenicity • Methemoglobinemia only with nitrites

  18. Contraindication • Nitrates are contraindicated in increase intracranial pressure. • Notice: Nitrates can be used safely in increase of intraocular pressure (Glucoma).

  19. Calcium channel blockers • Block calcium entry in myocardiumcausing : • decrease in myocardium contractility & heart rate Causing decrease in myocardium oxygen requirement.

  20. Continue • Block calcium entry in vascular smoothmuscles ( arteries & arterioles) causing : Decrease inperipheral resistance (after load)------decrease in oxygen requirement. Relief of coronary spasm.

  21. Classification of calcium channel blockers Dihydropyridine Nifedipine More selective as vasodilator Verapamil & Diltiazem More selective as cardiac depressant

  22. Pharmacokinetics • Given orally • Verapamil & Diltiazem can be given intravenously • Excreted in urine

  23. Clinical uses • In all types of angina but very effective in variant angina . Used in prophylactic therapy. • Hypertension • Supraventricular tachycardia • Peripheral vascular disease

  24. Adverse effects • Cardiac arrest, bradycardia ( verapamil & diltiazem ) • Reflex tachycardia ( nifedipine) • Fatigue & headche • Ankle edema • Constipation ( verapamil)

  25. Drug interaction • Verapamil or diltiazem with β-blockers causing bradycardia or cardiac arrest

  26. β-Adrenoceptor blocking drugs • Not vasodilators • Used in prophylactic treatment of angina through : Decrease in both heart rate & myocardial contractility that decrease myocardial oxygen requirement at rest & in exercise so improve exercise tolerance.

  27. Continue • Effective in the prophylactictreatment of all types of angina Except in variant angina. • Decrease mortality of patients with recentmyocardial infarction, heart failure & hypertension.

  28. Potassium channel openers Nicorandil Activation of potassium channels. Nitric oxide release. Arterio & venodilator. • Used as prophylactic therapy . • Side effects : Headache, flushing, dizziness.

  29. Fatty Acid Oxidase Inhibitors • Oxidation of fatty acids as a source of energy needs more oxygen than oxidation of carbohydrate. • Drugs that shift myocardial metabolism toward use of glucose (fatty acid oxidase inhibitors) have the potential of reducing the oxygen demand without change hemodynamics , e.g. trimetazidine

  30. Anticoagulants & Antiplatelets • Aspirin & Heparin decreasing the risk in unstable angina & acute coronary syndrome.

  31. Drug treatment of angina • Acute attack : Short acting nitrates or nitrites. • Prophylactic therapy ; • Long –acting nitrates. • Calcium channel blockers. • β- adrenoceptor blockers. • Potassium channel openers. • Fatty acid oxidase inhibitors

  32. Combination therapy • Nitrates and β-adrenoceptor blockers. • Calcium channel blockers( dihydropyridine) and β-adrenoceptor blockers . • Calcium channel blockers andnitrates. • Calcium channel blockers, β-adrenoceptorblockers, nitrates , antiplateles or anticoagulants.

  33. Surgical therapy • Ballon • Coronary by pass.

More Related